In order to verify the role of TGFβ in baicalein suppressing cervical cancer, SB431542, a TGFβ inhibitor, was employed to further assess the effect of baicalein on the expression of p-mTOR, mTOR, and E-cadherin. This evidence concerns the gene TGFB1 and cervical cancer.